CFTR and cystic fibrosis: One of the most significant advances in CF therapeutics has been the development of CFTR modulators, (both potentiators and correctors) as a corrective strategy, while bacteriophage therapy, vaccine strategies, and immunotherapy remain mostly experimental [3,80,86,87,88].